Eurobio Scientific Société anonyme (EPA:ALERS)

EPA:ALERS Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	21.77	49.3	47.49	92.92	65.1
Short-Term Investments	1.29	39.73	38.44	9.47	0.46
Cash & Short-Term Investments	23.07	89.03	85.94	102.39	65.56
Cash Growth	-74.09%	3.60%	-16.07%	56.18%	760.44%
Accounts Receivable	32.09	26.94	32.78	43.86	51.21
Other Receivables	3.97	3.74	6.09	8.32	5.52
Receivables	36.06	30.67	38.87	52.18	56.73
Inventory	26.92	21.45	21.65	16.29	12.93
Prepaid Expenses	1.31	1.01	0.57	0.47	-
Other Current Assets	1.18	1.39	1.53	2.27	-
Total Current Assets	89.59	143.91	148.69	173.6	135.21
Property, Plant & Equipment	12.77	12.3	12.66	10.05	9.92
Long-Term Investments	0.1	3.6	3.6	3.6	0
Goodwill	118.9	117.71	115.81	18.19	20.93
Other Intangible Assets	2.1	2.52	1.97	2.29	3.84
Long-Term Deferred Charges	32.52	32.9	37.2	1.28	1.66
Other Long-Term Assets	0	-	-	0	0
Total Assets	257.17	316.33	330.73	209.87	172.3
Accounts Payable	19.02	16.82	18.53	16.77	14.24
Accrued Expenses	6.15	6.07	9.63	6.57	5.21
Current Portion of Long-Term Debt	0.73	13.28	13.73	3.68	13.94
Current Portion of Leases	2.07	1.8	1.6	1.56	1.5
Current Income Taxes Payable	5.48	3.56	1.97	6.28	11.54
Current Unearned Revenue	0.18	0.2	0.44	0.16	0.18
Other Current Liabilities	2.76	2.64	1.25	1.05	1.39
Total Current Liabilities	44.15	52.88	57.32	36.11	47.98
Long-Term Debt	2.86	81.23	94.34	7.01	10.97
Long-Term Leases	4.12	4.35	3.97	3.44	3.31
Other Long-Term Liabilities	26.59	2.17	1.53	1.69	1.38
Total Liabilities	78.31	141.16	157.75	49	64.45
Common Stock	3.28	3.5	3.63	3.63	3.63
Additional Paid-In Capital	20.19	33.57	40.05	40.05	40.05
Comprehensive Income & Other	155.38	138.1	129.31	117.19	64.17
Total Common Equity	178.86	175.17	172.98	160.87	107.85
Shareholders' Equity	178.86	175.17	172.98	160.87	107.85
Total Liabilities & Equity	257.17	316.33	330.73	209.87	172.3
Total Debt	9.77	100.66	113.64	15.69	29.72
Net Cash (Debt)	13.3	-11.63	-27.7	86.7	35.84
Net Cash Growth	-	-	-	141.89%	-
Net Cash Per Share	1.30	-1.04	-2.44	7.97	3.18
Filing Date Shares Outstanding	10.03	10.04	10.22	10.85	11.21
Total Common Shares Outstanding	10.03	10.04	10.22	10.85	11.21
Working Capital	45.44	91.03	91.37	137.49	87.23
Book Value Per Share	17.82	17.44	16.92	14.83	9.62
Tangible Book Value	57.86	54.94	55.21	140.39	83.08
Tangible Book Value Per Share	5.77	5.47	5.40	12.94	7.41
Buildings	1.82	1.33	0.88	0.85	0.71
Machinery	1.09	0.76	1.12	1.12	8.5
Construction In Progress	0.05	0.48	0.45	0.01	1.21

Source: S&P Global Market Intelligence. Standard template. Financial Sources.